Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Dermatology drugs market 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Indication trends
2.1.4 Route of administration trends
2.1.5 Distribution channel trends
Chapter 3 Dermatology Drugs Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of skin disorders
3.2.1.2 Rise in research and development
3.2.1.3 Growing awareness of skin health and aesthetics among the younger population
3.2.1.4 Increasing geriatric population
3.2.1.5 Technological advancements in drug delivery
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory approval process
3.2.2.2 Adverse effects and safety concerns
3.2.2.3 Limited reimbursement policies and coverage for dermatology drugs
3.2.2.4 Availability of alternative non-pharmacological treatments
3.2.2.5 High cost of drug development
3.3 Growth potential analysis
3.3.1 By indication
3.3.2 By route of administration
3.3.3 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix, 2022
4.6 Strategic dashboard, 2022
Chapter 5 Dermatology Drugs Market Estimates and Forecast, By Indication (USD Million)
5.1 Key trends, by indication
5.2 Psoriasis
5.3 Atopic dermatitis
5.4 Acne
5.5 Skin cancer
5.6 Other indications
Chapter 6 Dermatology Drugs Market Estimates and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Parenteral injection
6.3 Topical
6.4 Oral
Chapter 7 Dermatology Drugs Market Estimates and Forecast, By Distribution Type (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacies
7.3 Retail pharmacies
Chapter 8 Dermatology Drugs Market Estimates and Forecast, By Region (USD Million)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Spain
8.2.5 Italy
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia
8.3.5 Rest of Asia Pacific
8.4 Latin America
8.4.1 Brazil
8.4.2 Mexico
8.4.3 Rest of Latin America
8.5 Middle East & Africa
8.5.1 South Africa
8.5.2 Saudi Arabia
8.5.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Novartis AG
9.2 Amgen Inc.
9.3 AbbVie Inc.
9.4 Johnson & Johnson
9.5 Leo Pharma A/S
9.6 Eli Lilly and Company
9.7 GlaxoSmithKline Plc
9.8 AstraZeneca plc
9.9 Pfizer Inc
9.10 Merck KGaA
9.11 Lupin
9.12 F. Hoffmann-La Roche Ltd.
9.13 Sanofi
